James G McLarnon: Microglial chemotactic signaling factors in Alzheimer’s disease. Am J Neurodegener Dis 2012;1(3):199-204. (Full text, PDF)
Jeffrey Cummings, Heath Gould, Kate Zhong: Advances in designs for Alzheimer’s disease clinical trials. Am J Neurodegener Dis 2012;1(3):205-216. (Full text, PDF)
Isabella Russo, Luigi Bubacco, Elisa Greggio: Exosomes-associated neurodegeneration and progression of Parkinson’s disease. Am J Neurodegener Dis 2012;1(3):217-225. (Full text, PDF)
Jose L Labandeira-Garcia, Jannette Rodriguez-Pallares, Ana I Rodríguez-Perez, Pablo Garrido-Gil, Begoña Villar-Cheda, Rita Valenzuela, Maria J Guerra: Brain angiotensin and dopaminergic degeneration: relevance to Parkinson’s disease. Am J Neurodegener Dis 2012;1(3):226-244. (Full text, PDF)
Gurdeep Marwarha, Othman Ghribi: Leptin signaling and Alzheimer’s disease. Am J Neurodegener Dis 2012;1(3):245-265. (Full text, PDF)
Thomas Simon O’Hagan, Whitney Wharton, Patrick G Kehoe: Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer’s disease. Am J Neurodegener Dis 2012;1(3):266-279. (Full text, PDF)
Daniel P Cardinali, Daniel E Vigo, Natividad Olivar, María F Vidal, Analía M Furio, Luis I Brusco: Therapeutic application of melatonin in mild cognitive impairment. Am J Neurodegener Dis 2012;1(3):280-291. (Full text, PDF)
François B Vialatte, Justin Dauwels, Toshimitsu Musha, Andrzej Cichocki: Audio representations of multi-channel EEG: a new tool for diagnosis of brain disorders. Am J Neurodegener Dis 2012;1(3):292-304. (Full text, PDF)
Mathew T Mizwicki, Milan Fiala, Larry Magpantay, Najib Aziz, James Sayre, Guanghao Liu, Avi Siani, Derrick Chan, Otoniel Martinez-Maza, Madhuri Chattopadhyay, Antonio La Cava: Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling. Am J Neurodegener Dis 2012;1(3):305-315. (Full text, PDF)
Meghan N Le, Wonhee Kim, Sangmook Lee, Ann C McKee, Garth F Hall: Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model. Am J Neurodegener Dis 2012;1(3):316-333. (Full text, PDF)
